Transformed streptomyces bacteria and method for producing bialaphos
By overexpressing genes in the bialaphos synthesis gene cluster, the modified Streptomyces bacterium improves bialaphos production efficiency, addressing limitations in existing production methods.
Patent Information
- Application Number
- JP2023074009
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-04-28
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Existing methods for producing bialaphos, a microbial herbicide, are limited in efficiency and productivity, necessitating the development of a modified Streptomyces bacterium that overexpresses genes in the bialaphos synthesis gene cluster to enhance production.
The Streptomyces bacterium is modified to overexpress one or more genes within the bialaphos synthesis gene cluster, utilizing specific polynucleotide sequences and hybridizing conditions to increase bialaphos production.
The modified bacterium significantly enhances bialaphos fermentation and production, achieving higher yields compared to unmodified strains.
Smart Images

Figure 2024158648000001_ABST
Abstract
Description
[Technical field]
[0001] The present disclosure relates generally to the microbial industry, and more particularly to bialaphos-producing bacteria that have been engineered to overexpress genes in the bialaphos synthesis gene cluster, thereby enhancing production of bialaphos. [Background technology]
[0002] In general, chemically synthesized pesticides are widely used as herbicides because they are stable, highly effective, and cost-effective. However, in recent years, from the viewpoint of environmental load, there is an increasing demand for herbicides derived from microbial metabolites to replace chemically synthesized pesticides. Herbicides derived from microbial metabolites are natural products, and therefore generally have the advantages of being highly biodegradable and having low environmental load.
[0003] Known herbicides derived from microbial metabolites include the amino acid herbicide bialaphos. Bialaphos is a herbicide derived from Streptomyces ( Streptomyces It is a secondary metabolite produced by actinomycetes belonging to the genus Streptomyces, e.g., Streptomyces hygroscopicus ( Streptomyces hygroscopicus It has been reported that bialaphos can be produced by the method of fermentation (Non-Patent Document 1). It has also been reported that the productivity of bialaphos has been improved by mutation breeding (Non-Patent Document 2).
[0004] In addition, Streptomyces hygroscopicus and Streptomyces viridochromogenes ( Streptomyces viridochromogenes ) functional analysis of the genes that constitute the bialaphos synthase gene cluster is currently underway (Non-Patent Documents 3 and 4). [Prior art documents] [Non-patent literature]
[0005] [Non-Patent Document 1] Tachibana K. et al., 1986, Journal of the Pesticide Science Society of Japan, 11, 297-304 [Non-Patent Document 2] Takebe et al., 1995, Journal of Bioengineering, 73, 413-24 [Non-Patent Document 3] Schwartz D. et al., 2004, Applied and Environmental Microbiology, 70, 7093-7102 [Non-Patent Document 4] Joshua A. V Blodgett et al. 2016, J Antibiot (Tokyo). 69, 15-25 Summary of the Invention [Problem to be solved by the invention]
[0006] An objective of the present invention is to provide a transformed Streptomyces bacterium having improved bialaphos-producing ability, and a method for producing bialaphos using the transformed Streptomyces bacterium. [Means for solving the problem]
[0007] As a result of intensive research conducted by the present inventors to achieve the above object, it has been found that one or more genes included in the bialaphos synthesis gene cluster can be overexpressed in a bacterium belonging to the genus Streptomyces. The present inventors have found that by increasing the temperature of the yeast culture medium, the productivity of bialaphos can be improved, and have thus completed the present invention.
[0008] The present invention provides the following: [1] Streptomyces ( Streptomyces ) bacteria, A bacterium that has been engineered to overexpress one or more genes in the bialaphos synthesis gene cluster, thereby enhancing the production of bialaphos. [2] The bacterium described in [1], wherein a gene contained in the bialaphos synthesis gene cluster is any one of the following polynucleotides: a) A polynucleotide comprising one or more base sequences selected from the group consisting of SEQ ID NOs: 1 to 24. D b) A complementary sequence of one or more base sequences selected from the group consisting of SEQ ID NOs: 1 to 24 and a string Polynucleotides that hybridize under gentle conditions c) a polypeptide encoding one or more amino acid sequences selected from the group consisting of SEQ ID NOs: 33 to 56; Ligands d) one or more amino acid sequences selected from the group consisting of SEQ ID NOs: 33 to 56 and 90% or more Polynucleotides encoding amino acid sequences with identity [3] The bacterium described in [1], wherein a gene contained in the bialaphos synthesis gene cluster is any one of the following polynucleotides: a) A polynucleotide comprising the base sequence of SEQ ID NO: 1 to 4 b) Hybridization under stringent conditions with the complementary sequences of the base sequences of SEQ ID NOs: 1 to 4 Soybean Polynucleotides c) Polynucleotides encoding the amino acid sequences of SEQ ID NOs: 33 to 36 d) Amino acid sequences having 90% or more identity with each of the amino acid sequences of SEQ ID NOs: 33 to 36 Polynucleotide encoding the acid sequence [4] The bacterium described in [1], wherein a gene contained in the bialaphos synthesis gene cluster is any one of the following polynucleotides: a) A polynucleotide comprising the base sequence of SEQ ID NO: 14 to 24 b) Hybridization under stringent conditions with the complementary sequences of the base sequences of SEQ ID NOs: 14 to 24 Hybridizing polynucleotide c) Polynucleotides encoding the amino acid sequences of SEQ ID NOs: 46 to 56 d) Amino acid sequences having 90% or more identity with each of the amino acid sequences of SEQ ID NOs: 46 to 56 Polynucleotide encoding the acid sequence [5] The bacterium described in [3], wherein the genes contained in the bialaphos synthetic gene cluster are polynucleotides comprising the base sequences of SEQ ID NOs: 26 and 27, or polynucleotides that hybridize under stringent conditions to the complementary sequences of SEQ ID NOs: 26 and 27, respectively. [6] The bacterium described in [4], wherein the genes contained in the bialaphos synthetic gene cluster are polynucleotides comprising the base sequences of SEQ ID NOs: 31 and 32, or polynucleotides that hybridize under stringent conditions to the complementary sequences of SEQ ID NOs: 31 and 32, respectively. [7] Streptomyces viridochromogenes ( Streptomyces viridochromogenes ) or Streptomyces hygroscopicus ( Streptomyces hygroscopicus The bacterium according to any one of [1] to [6], which is a bacterium belonging to the Bacillus subtilis. [8] A method for producing bialaphos, comprising the steps of: A production method comprising culturing the bacterium according to any one of [1] to [7] in a culture medium to produce and accumulate bialaphos in the culture medium and / or the bacterial cells. Effect of the Invention
[0009] According to the present invention, bialaphos can be efficiently produced by fermentation by using a Streptomyces bacterium that has been modified so as to overexpress one or more genes included in the bialaphos synthesis gene cluster. [Brief description of the drawings]
[0010]
Figure 1
Figure 2
Figure 3
[0011] In this specification, the strains with accession numbers beginning with the word JCM are registered with the Japan Collection of Microorganisms (RIKEN BioResource Center, Microbial Materials Research Center). Microorganisms stored in the Laboratory of Microorganisms (Hokkaido University, Tsukuba City, Ibaraki Prefecture, Japan, Postal Code: 305-0074, Address: 3-1-1 Takanodai, Tsukuba City, Ibaraki Prefecture) The number is assigned to the organization and is available from the organization.
[0012] As used herein, strains having accession numbers beginning with the word ATCC can be obtained from the American Type Culture Collection (Address: 10801 University Boulevard Manassas, VA 20110, United States of America).
[0013] In this specification, the strains with accession numbers beginning with the words NBRC are registered trademarks of the National Institute of Technology and Evaluation (NITE) (Postal Code: 292-0818, Address: 2-5-8 Kazusa Kamatari, Kisarazu City, Chiba Prefecture, Japan). This is a number given to microorganisms stored in the National Institute of Informatics (NII) and can be obtained from the Institute.
[0014] In this specification, the strains having accession numbers beginning with the word DSM are registered with the Deutsche Sammlung von This is the number assigned to the microorganisms stored at Mikroorganismen und Zellkulturen GmbH (Inhoffenstr. 7B 38124 Braunschweig Germany) and can be obtained from the institution.
[0015] <1> The Streptomyces of the present invention Streptomyces ) genus bacteria The Streptomyces bacterium of the present invention is a bacterium that is a member of the bialaphos synthesis gene cluster. The bacterium may be any Streptomyces bacterium, so long as it has been modified to overexpress one or more genes.
[0016] The Streptomyces bacterium may inherently have the ability to produce bialaphos, or may be modified to have the ability to produce bialaphos using a mutation method or DNA recombinant technology. The bacterium of the present invention can be obtained by modifying a Streptomyces bacterium that inherently has bialaphos-producing ability, or a Streptomyces bacterium that has been imparted with bialaphos-producing ability, so as to overexpress a gene included in the bialaphos synthesis gene cluster, thereby enhancing the production of bialaphos.
[0017] The term "bialaphos-producing ability" may refer to the ability of a Streptomyces bacterium to produce and accumulate bialaphos in a culture medium and / or in the bacterial cells to an extent that it can be recovered from the medium and / or in the bacterial cells when the bacterium is cultured in the culture medium.
[0018] "Bialaphos" is also known as phosphinothricin tripeptide (PTT) and is a phosphinothricin (PT) compound consisting of two molecules of L-alanine and one molecule of the amino acid. Bialaphos has the following chemical formula:
[0019] [ka]
[0020] The term "bialaphos" is not limited to the free form of bialaphos, but may also include its salts or hydrates, or adducts formed by bialaphos and other organic or inorganic compounds. That is, the term "bialaphos" may, for example, mean the free form of bialaphos or a hydrate or adduct of bialaphos. The term "bialaphos" may, for example, include salts such as sodium salt, potassium salt, ammonium salt, monohydrate, dihydrate, trihydrate, monohydrochloride, dihydrochloride, and internal salts such as zwitterions of bialaphos acid.
[0021] Examples of Streptomyces bacteria include, but are not limited to, Streptomyces viridomogenes ( Streptomyces viridochromogenes and bacteria belonging to Streptomyces hygroscopicus. Among them, bacteria belonging to Streptomyces viridochromogenes or bacteria belonging to Streptomyces hygroscopicus are preferred, and bacteria belonging to Streptomyces viridochromogenes are more preferred.
[0022] Examples of bacteria belonging to Streptomyces viridochromogenes include Streptomyces viridochromogenes JCM4977 strain, Tue57 strain (Weitnauer, G. et. al., (2002). Microbiology, 148(2), 373-379.), subsp. komabensis (ATCC29814 strain), and subsp. sulfomycini (NBRC13830) strain. Bacteria belonging to Streptomyces hygroscopicus include subsp. hygroscopicus (ATCC21589), subsp. ascomyceticus (ATCC14891), subsp. yingchengensis (Qin, Z. et al. (1994). J. Bacterial., 176(7), 2090-2095.), subsp. limoneus (ATCC21431), subsp. duamyceticus (JCM4427), subsp. Enhygrus (DSM41913), subsp. crystallogenes (NBRC16551), subsp. azalomyceticus (ATCC13810), and subsp. jinggangensis (Yu, Y. et. al., (2005). Appl. Environ. Microbiol., 71(9), 5066-5076.), subsp. aabomyceticus (ATCC21449), and subsp. hialomyceticus (NBRC13946).
[0023] <2> Increasing bialaphos production The bacterium of the present invention overexpresses one or more genes contained in the bialaphos synthesis gene cluster. The bacterium has been modified to express bialaphos, thereby enhancing production of bialaphos.
[0024] The bialaphos synthesis gene cluster is a group of multiple genes involved in the synthesis of bialaphos. For example, as shown in Figure 1, the bialaphos synthesis gene cluster of Streptomyces viridochromogenes contains the following protein-coding genes in order from the 5' end: , phpA gene, phsB gene, phpB gene, phsC gene, pmi gene, phpC gene, phpD gene The phpE gene, ppm gene, ppd gene, phpF gene, phpG gene, phpH gene, phpI gene, phpJ gene, phpK gene, pms gene, phsA gene, pat gene, dea gene, phpL gene, phpM gene, phpN gene, and phpR gene are known to exist ( Non-patent literature 4).
[0025] Bialaphos is a secondary metabolite synthesized via a number of intermediates using phosphoenolpyruvate (PEP) as a substrate. The results of an analysis of the synthesis pathway of bialaphos and the functions of genes in the bialaphos synthesis gene cluster have been reported. First, phosphonopyruvate is synthesized from phosphoenolpyruvate. This reaction is carried out by a protein encoded by the ppm gene. The protein has been reported to be a PEP phosphomutase.
[0026] Next, phosphonopyruvic acid is converted to phosphonoacetaldehyde. This reaction is carried out by the protein encoded by the ppd gene. The protein is reported to be phosphonopyruvate decarboxylase.
[0027] Next, hydroxyethylphosphonate is synthesized from phosphonoacetaldehyde. This reaction is carried out by the protein encoded by the phpC gene. and the protein is reported to be a phosphonoacetaldehyde reductase.
[0028] Next, hydroxymethylphosphonate is synthesized from hydroxyethylphosphonate. This reaction is carried out by the protein encoded by the phpD gene, which is reported to be hydroxyethylphosphonate dioxygenase.
[0029] Next, phosphonoformaldehyde is synthesized from hydroxymethylphosphonic acid. This reaction is carried out by the protein encoded by the phpE gene. and the protein is reported to be hydroxymethylphosphonate dehydrogenase.
[0030] Next, phosphonoformate is synthesized from phosphonoformaldehyde by the protein encoded by the phpJ gene, which is presumed to be phosphonoformaldehyde dehydrogenase.
[0031] Next, cytidine monophosphate-5'-phosphonoformic acid (CMP-5'-PF) is synthesized from phosphonoformic acid. The protein responsible for this reaction is the protein encoded by the phpF gene, which is cytidine triphosphate (CTP):phosphonoformate nucleotidyltransferase. It has been reported that
[0032] It is speculated that phosphonoformylglycerate is then synthesized from cytidine monophosphate-5'-phosphonoformate, and this reaction is carried out by the phpG gene. It is speculated that the protein is encoded by
[0033] It is speculated that carboxyphosphonoenolpyruvate is then synthesized from phosphonoformylglycerate, and that the protein encoded by the phpH gene is responsible for this reaction.
[0034] Next, phosphinopyruvate is synthesized from carboxyphosphonoenolpyruvate. This reaction is carried out by the protein encoded by the phpI gene. and the protein is reported to be a carboxyphosphonoenolpyruvate phosphonomutase.
[0035] Next, phosphinopyruvic acid is converted to phosphinomethylmalate. ) is synthesized. This reaction is carried out by the protein encoded by the pms gene, The protein is reported to be a phosphinomethylmalate synthase.
[0036] Next, isophosphinomethylmalate is synthesized from phosphinomethylmalate. This reaction is carried out by the protein encoded by the pmi gene. The protein is reported to be phosphinomethylmalate isomerase.
[0037] Next, demethylphosphinothricin is synthesized from isophosphinomethylmalate. The genes involved in this reaction have not yet been reported.
[0038] Next, N-acetyl-demethylphosphinothricin is synthesized from demethylphosphinothricin. This reaction is controlled by the pat gene. The encoded protein is reported to be demethylphosphinothricin N-acetyltransferase.
[0039] Next, N-acetyl-demethylphosphinothricyl-alanyl-alanine is synthesized from N-acetyl-demethylphosphinothricin. In this reaction, two molecules of alanine are added to N-acetyl-demethylphosphinothricin. is added. This reaction is carried out by a group of proteins encoded by the phpA, phsB, phsC, phsA, phpL, and phpM genes. It has been reported that the proteins encoded by the phpA, phsB, phsC, and phsA genes are non-ribosomal peptide synthetases (NRPSs). The proteins encoded by the phpL and phpM genes are presumed to be type II thioesterases.
[0040] Next, N-acetyl-demethylphosphinotrisyl-alanyl-alanine was converted to N-acetyl- N-acetylphosphinothricyl-alanyl-alanine The protein responsible for this reaction is encoded by the phpK gene, and this protein has been reported to be N-acetyl-PTP-methylase.
[0041] Finally, bialaphos is synthesized from N-acetylphosphinotrisyl-alanyl-alanine. This reaction is carried out by the protein encoded by the dea gene. has been reported to be an N-acetyl-PTT deacetylase.
[0042] The phpR gene has been reported to be a regulator of bialaphos synthesis. The phpB gene and the phpN gene are genes encoding proteins of unknown function.
[0043] Streptomyces viridochromogenes ( S. viridochromogenes ) JCM4977 strain has The sequence numbers of the base sequences of the genes contained in the bialaphos synthesis gene cluster are shown in Table 1.
[0044] [Table 1]
[0045] In the present invention, the "gene contained in the bialaphos synthetic gene cluster" that is overexpressed is not particularly limited as long as it is a gene that encodes a protein, but is preferably a polynucleotide containing one or more base sequences selected from the group consisting of SEQ ID NOs: 1 to 24, or a polynucleotide that hybridizes under stringent conditions to their complementary sequences (however, limited to polynucleotides that maintain the function of each encoded protein). Among these, polynucleotides containing the base sequences of SEQ ID NOs: 1 to 4, or polynucleotides that hybridize under stringent conditions with the complementary sequences of the base sequences of SEQ ID NOs: 1 to 4 (limited to polynucleotides that maintain the functions of each encoded protein). Also, polynucleotides containing the base sequences of SEQ ID NOs: 14 to 24, or polynucleotides that hybridize under stringent conditions with the complementary sequences of the base sequences of SEQ ID NOs: 14 to 24 (provided that the functions of the encoded proteins are maintained) are also included. It is more preferable that the above-mentioned Furthermore, it is more preferable that the polynucleotide is a polynucleotide containing the base sequence of any one of SEQ ID NOs: 9 to 24, or a polynucleotide that hybridizes under stringent conditions with the complementary sequence of each of the base sequences of SEQ ID NOs: 9 to 24 (however, this is limited to polynucleotides that maintain the function of each encoded protein). Furthermore, it is more preferable that the polynucleotide is a polynucleotide containing the base sequence of any one of SEQ ID NOs: 5 to 24, or a polynucleotide that hybridizes under stringent conditions with the complementary sequence of each of the base sequences of SEQ ID NOs: 5 to 24 (however, this is limited to polynucleotides that maintain the function of each encoded protein).
[0046] The nucleotide sequence of SEQ ID NO: 25 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) The full-length base sequence of the bialaphos synthesis gene cluster of the JCM4977 strain. do.
[0047] The nucleotide sequence of SEQ ID NO: 26 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) A partial nucleotide sequence of the genome of the JCM4977 strain, which constitutes the phpA gene. The base sequence from the 555 bp upstream to the stop codon of the phpB gene (shown in Figure 1) The Sq1 region is
[0048] The nucleotide sequence of SEQ ID NO: 27 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) A partial nucleotide sequence of the genome of the JCM4977 strain, which is the stop sequence of the phpB gene This is the nucleotide sequence from the base one base downstream of the codon to the stop codon of the phsC gene (the Sq2 region shown in Figure 1).
[0049] The nucleotide sequence of SEQ ID NO:28 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) A partial nucleotide sequence of the genome of the JCM4977 strain, which is a stop gene of the phsC gene. This is the base sequence from the base one base downstream of the codon to the stop codon of the pmi gene (the Sq3 region shown in Figure 1).
[0050] The nucleotide sequence of SEQ ID NO:29 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) This is the base sequence of a portion of the genome of the JCM4977 strain, which is the base sequence from 10 bases downstream of the stop codon of the pmi gene to the stop codon of the phpE gene (the Sq4 region shown in Figure 1).
[0051] The nucleotide sequence of SEQ ID NO: 30 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) A partial nucleotide sequence of the genome of the JCM4977 strain, which is the stop gene of the phpE gene. This is the base sequence from the base one base downstream of the codon to the stop codon of the phpH gene (the Sq5 region shown in Figure 1).
[0052] The nucleotide sequence of SEQ ID NO:31 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) A partial nucleotide sequence of the genome of the JCM4977 strain, which contains the stop codon of phpH This is the base sequence from the base one downstream of to the SbfI site (CCTGCAGG) in the base sequence of the phpJ gene (the Sq6 region shown in FIG. 1).
[0053] The nucleotide sequence of SEQ ID NO: 32 is derived from Streptomyces viridochromogenes ( S. viridochromogenes ) A partial nucleotide sequence of the genome of the JCM4977 strain, which is the nucleotide sequence of the phpJ gene. This is the nucleotide sequence from the SbfI site (CCTGCAGG) in the vector to the stop codon of phpR (the F3 region shown in FIG. 1).
[0054] The polynucleotide of SEQ ID NO: 25, which corresponds to the full length of the bialaphos synthetic gene cluster, It may be overexpressed. Also, a polynucleotide that hybridizes with the complementary sequence of SEQ ID NO: 25 under stringent conditions (limited to a polynucleotide that exerts a bialaphos enhancing effect when overexpressed) may be overexpressed. Additionally, each region can be overexpressed. For example, a polynucleotide containing one or more base sequences selected from the group consisting of SEQ ID NOs: 26 and 27, or a polynucleotide that hybridizes to its complementary sequence under stringent conditions (limited to polynucleotides that exert a bialaphos enhancing effect when overexpressed) can be overexpressed. For example, a polynucleotide containing one or more base sequences selected from the group consisting of SEQ ID NOs: 31 and 32, or a polynucleotide that hybridizes to its complementary sequence under stringent conditions (limited to polynucleotides that exert a bialaphos enhancing effect when overexpressed) can be overexpressed. For example, a polynucleotide containing one or more base sequences selected from the group consisting of SEQ ID NOs: 30, 31, and 32, or a polynucleotide that hybridizes to its complementary sequence under stringent conditions (limited to polynucleotides that exert a bialaphos-enhancing effect when overexpressed) can be overexpressed. For example, a polynucleotide containing one or more base sequences selected from the group consisting of SEQ ID NOs: 28, 29, 30, 31, and 32, or a polynucleotide that hybridizes to its complementary sequence under stringent conditions (limited to polynucleotides that exert a bialaphos enhancing effect when overexpressed), can be overexpressed.
[0055] "Stringent conditions" refer to conditions under which so-called specific hybrids are formed and non-specific hybrids are not formed. For example, the conditions include conditions under which two DNAs with high identity, preferably two DNAs with an identity of 90% or more, particularly preferably two DNAs with an identity of 95% or more, hybridize with each other, but two DNAs with lower identity do not hybridize. For example, the conditions include conditions of washing once, preferably two to three times, at a salt concentration and temperature corresponding to 60°C, 0.1×SSC, 0.1% SDS, more preferably 68°C, 0.1×SSC, 0.1% SDS. That is, for example, a "gene contained in the bialaphos synthetic gene cluster" may have a base sequence that has an identity of 90% or more, particularly preferably 95% or more, to any of the base sequences of SEQ ID NOs: 1 to 24.
[0056] Furthermore, the "gene contained in the bialaphos synthetic gene cluster" of the present invention may have a nucleotide sequence containing one or several nucleotide substitutions, deletions, insertions, or additions in the nucleotide sequence of any of SEQ ID NOs: 1 to 32. Here, one or several means, for example, 1 to 50, 1 to 30, 1 to 10, or 1 to 5. The "gene contained in the bialaphos synthetic gene cluster" of the present invention may be a partial sequence in which the 5'-terminus and / or 3'-terminus of the nucleotide sequence of any of SEQ ID NOs: 1 to 24 is deleted.
[0057] The protein encoded by the "gene contained in the bialaphos synthetic gene cluster" of the present invention is preferably a protein comprising one or more amino acid sequences selected from the group consisting of SEQ ID NOs: 33 to 56, or an analog thereof, more preferably a protein comprising the amino acid sequences of SEQ ID NOs: 33 to 36, or an analog thereof, and even more preferably a protein comprising the amino acid sequences of SEQ ID NOs: 46 to 56, or an analog thereof. As shown in Table 1, the amino acid sequences of SEQ ID NOs: 33 to 56 are the amino acid sequences of proteins encoded by polynucleotides having the base sequences of SEQ ID NOs: 1 to 24, respectively.
[0058] An "analog of the protein of the amino acid sequence of SEQ ID NO: 33" is an analog of the protein of the amino acid sequence of SEQ ID NO: 33, which has one or several amino acid residue substitutions, deletions, insertions, and / or deletions, compared to the protein of the amino acid sequence of SEQ ID NO: 33. A protein that has one or more mutations in its sequence, whether they are a mutation or an addition. The number of mutations in the analog protein depends on the position of the amino acid residue in the three-dimensional structure of the protein or the type of amino acid residue. The number of changes in the analog protein is not strictly limited, but may be 1 to 30, in another example, 1 to 20, in another example, 1 to 15, in another example, 1 to 10, or in another example, 1 to 5 in the amino acid sequence of SEQ ID NO: 33. In addition, it may be 90% or more, 91% or more, 92% or more, 93% or more, 94% or more of the entire amino acid sequence of SEQ ID NO: 33. , 95% or more, 96% or more, 97% or more, 98% or more, or 99% or more homology to the amino acid sequence The same applies to "analogs of proteins having the amino acid sequences of SEQ ID NOs: 34 to 56."
[0059] The expression "genes contained in the bialaphos synthesis gene cluster are overexpressed" may mean that the expression level (i.e., amount of expression) of the genes contained in the bialaphos synthesis gene cluster is higher than that in an unmodified bacterial strain. Thus, the term "genes contained in the bialaphos synthesis gene cluster are overexpressed" may be used interchangeably or equivalently with the term "expression of genes contained in the bialaphos synthesis gene cluster is enhanced or increased". The increase in the expression level of the genes contained in the bialaphos synthesis gene cluster may be measured, for example, as an increase in the expression level of the genes per cell (which may be the average expression level of the genes per cell). The bacteria may be modified such that the expression level of the genes contained in the bialaphos synthesis gene cluster per cell is increased, for example, to 150% or more, 200% or more, or 300% or more of the expression level in an unmodified bacterial strain.
[0060] Methods that can be used to enhance the expression of genes contained in the bialaphos synthetic gene cluster include, but are not limited to, increasing the copy number of the genes contained in the bialaphos synthetic gene cluster, for example, the copy number of the genes in the bacterial chromosome and / or the copy number of the genes in an autonomously replicating plasmid carried by the bacterium. The copy number of the genes can be increased, for example, by introducing the genes into the bacterial chromosome and / or by introducing an autonomously replicating plasmid containing the genes into the bacterium. Such modification of Streptomyces bacteria can be carried out by genetic engineering techniques well known to those skilled in the art.
[0061] Vectors include, but are not limited to, plasmids such as pSET152, pGM1190, pKC1139, SCP2, SLP1.2, and pIJ101. The gene can also be introduced into the bacterial chromosomal DNA, for example, by homologous recombination. The genes in the bialaphos synthesis gene cluster may be introduced in one copy, or in two or more copies. For example, multiple copies may be introduced into the chromosomal DNA by homologous recombination. By using an array with multiple copies of bialaphos, multiple copies of the bialaphos complex are introduced into the chromosomal DNA. It is possible to introduce genes contained in a gene cluster into the chromosomal DNA. Examples of sequences having a peak include, but are not limited to, repetitive DNA and transposable elements. In addition, multiple copies of a gene contained in the bialaphos synthesis gene cluster can be introduced into chromosomal DNA by incorporating the gene into a transposon and transferring the gene.
[0062] Another method that can be used to enhance the expression of a gene contained in the bialaphos synthetic gene cluster is to increase the expression level of the gene by modifying the expression control region of the gene contained in the bialaphos synthetic gene cluster. The expression control region of the gene can be modified, for example, by introducing a wild-type and / or modified foreign expression control region into the original expression control region of the gene. An "expression control region" is also called an "expression control sequence." Expression control regions include promoters, enhancers, attenuators and termination signals, antitermination signals, and ribosome binding sites. (RBS), and other expression control elements (e.g., repressors or inducers). Such regulatory regions include, for example, regions to which the ribozyme binds, and / or binding sites for transcriptional and translational regulatory proteins in the transcribed mRNA. Such regulatory regions are described, for example, in Sambrook J., Fritsch EF and Maniatis T., "Molecular Cloning: A Laboratory Manual", 2nd ed., Cold Spring Harbor Laboratory Press (1989). Bialaphos synthetic gene Modification of the expression control regions of the genes in the child cluster may be combined with an increase in the copy number of the genes in the bialaphos synthesis gene cluster.
[0063] Examples of promoters suitable for enhancing the expression of the bialaphos synthesis gene cluster genes include, for example, the lac promoter, the trp promoter, the trc promoter, the tac promoter, the tet promoter, the araBAD promoter, the rpoH promoter, the msrA promoter, the Pm1 promoter (from the genus Bifidobacterium), and the PR and PL promoters of lambda phage. Promoters known as strong promoters of motors, etc., and pmi promoters Strong promoters that confer high levels of gene expression in Streptomyces bacteria can be used.
[0064] Preparation of plasmid DNA, DNA cleavage, DNA ligation, DNA transformation, selection of oligonucleotides as primers, introduction of mutations, and other molecular manipulation and cloning of recombinant DNA molecules. Methods for cloning may be conventional methods well known to those skilled in the art. Such methods are described, for example, in Sambrook J., Fritsch EF and Maniatis T., "Molecular Cloning: Laboratory Manual”, 2nd ed., Cold Spring Harbor Laboratory Press (1989), or Green MR and Sambrook JR, “Molecular Cloning: A Laboratory Manual”, 4th ed., Cold Spring Harbor Laboratory Press (2012), or Bernard R. Glick, Jack J. Pasternak and Cheryl L. Patten, “Molecular Biotechnology: principles and applications of recombinant DNA”, 4th ed., Washington, DC, ASM Press (2009).
[0065] Recombinant DNA manipulation techniques include, for example, transformation, transfection, and immunization. Any method can be used, including conventional methods such as transformation, transfection, infection, conjugation, or mobilization of bacteria with DNA encoding the protein. By this, the bacterium is endowed with the ability to synthesize the protein encoded by the DNA. Methods of transformation, transfection, infection, conjugation, and mobilization can include any method.
[0066] In addition to the above-mentioned properties, the bacteria may have specific properties such as various nutritional requirements, drug resistance, drug sensitivity, drug dependency, etc., without departing from the scope of the present invention.
[0067] The copy number of genes in the bialaphos synthesis gene cluster and the presence or absence of genes can be determined, for example, by restriction of chromosomal DNA and using probes based on the gene sequences. Southern blotting or fluorescent in situ hybridization (FISH) The level of gene expression can be determined by measuring the amount of mRNA transcribed from the gene using a variety of well-known methods, such as Northern blotting or quantitative RT-PCR.
[0068] "Enhanced production of bialaphos" may mean that the amount of bialaphos produced is increased in a bacterium modified to overexpress a gene contained in the bialaphos synthesis gene cluster, as compared to an unmodified bacterium. Specifically, for example, it may mean that the modified bacterium produces and accumulates 1.1-fold or more, 1.3-fold or more, or 1.5-fold or more of bialaphos in the medium and / or in the bacterial cells, as compared to an unmodified bacterium. The term "unmodified bacterium" may mean a bacterial strain that can serve as a control for the above comparison. "Unmodified bacterium" may be defined as " The term "unmodified strain" or "unmodified bacterial strain" is also used. Examples of unmodified bacterial strains include wild-type and parent strains of bacteria belonging to the genus Streptomyces (e.g., Streptomyces viridochromogenes). A specific example of an unmodified bacterial strain is the Streptomyces viridochromogenes JCM4977 strain.
[0069] The amount of bialaphos produced can be measured by a known method. For example, bialaphos accumulated in the medium or cells can be measured by LC-MS / MS.
[0070] <3> The method for producing bialaphos according to the present invention The method for producing bialaphos of the present invention comprises culturing the Streptomyces bacterium of the present invention in a culture medium to produce and accumulate bialaphos in the culture medium and / or the bacteria. Bialaphos can be produced in the form as described above. Bialaphos can be produced in particular in a free form, a salt thereof, or a mixture thereof. For example, salts such as sodium salt, potassium salt, and ammonium salt of bialaphos can be produced by the method.
[0071] The method for producing bialaphos of the present invention includes a step of culturing the Streptomyces bacterium of the present invention in a culture medium to produce and accumulate bialaphos in the culture medium and / or the bacterial cells, and then recovering bialaphos from the culture medium and / or the bacterial cells. The method may optionally include a step of purifying bialaphos from the culture medium and / or the bacterial cells.
[0072] The cultivation of the bacteria and the optional recovery and purification of bialaphos from the medium etc. can be carried out in the same manner as in conventional fermentation methods for producing bialaphos using microorganisms. The culture medium can be a synthetic medium or a natural medium, such as a typical medium containing a carbon source, a nitrogen source, a sulfur source, a phosphorus source, inorganic ions, and other organic and inorganic components as necessary. As the carbon source, sugars such as glucose, sucrose, lactose, galactose, fructose, arabinose, maltose, xylose, trehalose, ribose, starch hydrolysate, etc., alcohols such as ethanol, glycerol, mannitol, sorbitol, organic acids such as gluconic acid, fumaric acid, citric acid, malic acid, succinic acid, fatty acids, etc. can be used. As the nitrogen source, inorganic ammonium salts such as ammonium sulfate, ammonium chloride, ammonium phosphate, etc., organic nitrogen such as soybean hydrolysate, ammonia gas, ammonia water, etc. can be used. In addition, peptone, yeast extract, meat extract, malt extract, corn steep liquor, cottonseed cake, etc. can also be used. The medium may contain one or more of these nitrogen sources. Sulfur sources include ammonium sulfate, sulfur, and the like. Examples of suitable sources of phosphorus include magnesium sulfate, ferrous sulfate, and manganese sulfate. The medium may contain a phosphorus source in addition to the carbon source, nitrogen source, and sulfur source. Examples of suitable phosphorus sources include potassium dihydrogen phosphate, dipotassium hydrogen phosphate, and phosphate polymers such as pyrophosphate. Vitamins such as vitamin B1, vitamin B2, vitamin B6, nicotinic acid, nicotinamide, and vitamin B12 may be used. and other necessary substances, such as adenine, nucleic acids such as RNA, amino acids, peptones, and casamino acids. Organic nutrients such as acid and yeast extract can be present in appropriate amounts (even trace amounts). In addition to these, small amounts of calcium phosphate, iron ions, manganese ions, etc. can be added if necessary.
[0073] The culture can be carried out under conditions suitable for culturing the bacteria used in the method for producing bialaphos. For example, the culture can be carried out under aerobic conditions for 16 to 72 hours, or 16 to 24 hours. The culture temperature during the culture can be controlled within the range of 27 to 45°C, or 27 to 37°C. The pH can be adjusted between 5 and 8, or between 6 and 7.5. The pH can be adjusted by using an inorganic or organic acidic or alkaline substance, such as urea, calcium carbonate, or ammonia gas.
[0074] After the cultivation, bialaphos can be collected from the culture medium. Alalaphos can be recovered, specifically, by disrupting the cells, removing solids such as the cells and cell disruption suspension (also called cell debris) to obtain a supernatant, and recovering bialaphos from the supernatant. Disruption of the cells can be carried out by well-known methods such as ultrasonic disruption using high-frequency sound waves. Removal of solids can be carried out by centrifugation or membrane filtration. Recovery of bialaphos from the culture medium or supernatant can be carried out by conventional techniques such as concentration, crystallization, ion exchange chromatography, medium or high pressure liquid chromatography, or a combination thereof.
[0075] The recovered bialaphos may contain, in addition to bialaphos, for example, cells, medium components, water, and metabolic by-products of microorganisms. Bialaphos acid may be purified to a desired degree. The purity of the recovered bialaphos may be, for example, 50% or more, preferably 85% or more, and particularly preferably 95% or more. EXAMPLES
[0076] Examples of the present invention will be described below, but the present invention is not limited to these examples.
[0077] [Example 1] The full-length and stepwise shortened gene cluster fragments of the bialaphos synthesis gene cluster were introduced into Streptomyces viridochromogenes, and bialaphos productivity was evaluated.
[0078] (1) Construction of plasmid for gene transfer The plasmid for gene transfer was based on pSET152 (Creative Biogene, Cat. No. OVT2796). Streptomyces viridomogenes ( S. viridochromogenes ) Using the genomic DNA of the JCM4977 strain as a template, DNA fragments of the Sq1 to Sq6 and F3 regions of the bialaphos synthase gene cluster were amplified by PCR using the primer sets shown in Table 2. First, the obtained XbaI-EcoRV fragment of F3 was inserted into the XbaI-EcoRV gap of pSET152 to construct a plasmid incorporating F3 (F3 in Figure 1). Next, the NheI-SbfI fragment of Sq6 and the SbfI-EcoRV fragment of F3 were inserted into the XbaI-EcoRV gap of pSET152 to construct a plasmid incorporating Sq6F3 (Sq6F3 in Figure 1). Next, the MunI-SpeI fragment of Sq5 was inserted into the EcoRI-XbaI gap of the plasmid incorporating Sq6F3. The MunI-SpeI fragment of Sq4, the MunI-SpeI fragment of Sq3, the MunI-SpeI fragment of Sq2, and the MunI-SpeI fragment of Sq1 were inserted into the plasmid pG1 and pG2, respectively, to construct a plasmid pG1 and pG2. By inserting each of the fragments, a plasmid was constructed in which the full-length cluster and the intermediate-length cluster fragments (Sq3-6F3, Sq5-6F3, Sq6F3, and F3) shown in FIG. 1 were introduced into pSET152.
[0079] [Table 2]
[0080] The base sequences of the primer sets shown in Table 2 are shown in Table 3.
[0081] [Table 3] In the table, the base sequences are from left to right, from the 5' end to the 3' end.
[0082] (2) Transformation of E. coli for conjugation Each of the constructed plasmids was used to transform E. coli by electroporation according to the following procedure. First, competent cells of the E. coli S17-1 strain were prepared by the following procedure. Streaking the glycerol stock of E. coli S17-1 on an LB plate, then incubating at 37°C for 16-20 hours. A single colony was obtained by inoculating the single colony into 2.5 mL of LB medium and incubated at 37 °C. The mixture was pre-cultured at 37°C, 200 rpm for 16 hours. 200 μl of the pre-culture was inoculated into 20 mL of LB medium and incubated at 37°C, 200 rpm for 16 hours at OD 600 Culture was continued until the β-aspartate concentration reached 0.5-0.8. The cells were harvested by centrifugation (4°C, 3000 x g, 10 min). Then, discard the supernatant, add 20 mL of ice-cold sterile water, and gently suspend the pellet with a pipette. After repeating the steps of collecting and washing the bacteria once more, the bacteria were collected again by centrifugation (4°C, 3000 xg, 10 min), the supernatant was discarded, and the pellet was gently suspended in 200 μl of ice-cold 10% glycerol using a pipette. 50 μl of this suspension was added to each tube (Eppendorf tube). Competent cells of the S17-1 strain were prepared by dispensing the cells into a culture flask (manufactured by Eppendorf).
[0083] The constructed plasmid (~2 μL) was added to the prepared competent cells and electroporated. The cells were transferred to a poration cell (Bio-Rad Laboratories, Inc.) and then left to stand on ice for 10 minutes. An electric pulse of 1.8 kV, 25 μF, and 200 Ω was applied, and 1 mL of LB medium was added. The bacteria were then harvested at 20,000 xg for 1 minute, the supernatant was removed, and the bacteria were resuspended in an appropriate amount of medium, spread on 2xYT agar medium containing 50 μg / mL apramycin, and cultured overnight at 37°C. In addition, the same procedure was carried out except that an empty vector (pSET152) was used instead of the constructed plasmid. Escherichia coli was transformed and cultured according to the procedure of 1. above, and this was used as a negative control.
[0084] (3) Transformation of Streptomyces bacteria The transformed E. coli was used to transform Streptomyces bacteria by conjugal transfer according to the following procedure. Each strain of E. coli S17-1 carrying the transformation plasmid obtained by the above culture was inoculated into 2 mL of LB medium containing 50 μg / mL apramycin and precultured overnight at 37° C. and 200 rpm. 100 μL of the culture was inoculated into 10 mL of fresh LB medium (containing 50 μg / mL apramycin) and the OD 600 The cells were harvested at 8000 xg for 10 minutes, the supernatant was discarded, and the harvested cells were suspended (washed) in 10 mL of LB medium by pipetting. The washing process was repeated twice to remove antibiotics contained in the culture medium. The collected bacterial pellet was then resuspended in 1 mL of LB medium. 500 μL of this E. coli suspension was then added to the same The cells were suspended in 500 μl of 2×YT medium, heat-shocked at 50°C for 10 minutes, and then left on ice. Streptomyces viridochromogenes ( S. viridochromogenes )JCM4977 The spores were mixed with the strain spores and centrifuged briefly. Ten, 1% by weight starch, 0.2% by weight calcium carbonate, 0.2% by weight ammonium sulfate, 0.1% by weight dipotassium hydrogen phosphate, 0.1% by weight magnesium sulfate heptahydrate, 0.1% by weight sodium chloride Thorium, 0.1% by weight Yeast extract, 0.0001% by weight Iron(II) sulfate heptahydrate, 0.0001% by weight The actinomycetes were plated on a mixture of manganese chloride heptahydrate and 0.0001 wt% zinc sulfate heptahydrate and cultured at 28°C for approximately two weeks to obtain the culture medium. After the above centrifugation, the supernatant was discarded, leaving about 50 μL, and the bacterial pellet was resuspended in the remaining supernatant, after which a dilution series was prepared with sterile water, and 100 μL was applied to 20 ml of ISP4 plate medium and cultured overnight at 28° C. 0.5 mg of nalidixic acid and an antibiotic solution (20 μl of 50 mg / mL apramycin) were added to 1 ml of sterile water, which was then layered on the medium and cultured at 28° C. for an additional 3 to 5 days to obtain each transformant of Streptomyces bacteria.
[0085] (4) Flask culture The obtained transformants were cultured in YS medium (1% by weight soluble starch, 0.2% by weight yeast The bacteria were inoculated into a 500-ml baffled flask containing 150 ml of the extract and precultured at 140 rpm and 28°C for 3 days. 1 ml of the preculture solution was transferred to MYG medium (1% by weight) containing 50 μg / mL apramycin. 500 ml of 150 ml of malt extract, 0.4% by weight yeast extract, 0.4% by weight glucose) The bacteria were inoculated into a baffled flask and cultured at 28°C at 140 rpm until the third day and at 85 rpm thereafter.
[0086] (5) Measurement of Bialaphos concentration After 6 days of flask culture, 2 ml of the culture solution was centrifuged at 15,000 rpm for 15 minutes, and the supernatant was collected. After appropriate dilution, the bialaphos concentration was measured by LC-MS / MS analysis. A calibration curve was prepared using bialaphos of known concentration.
[0087] (6) Results The bialaphos productivity of each transformant is shown in Figure 2. As shown in Figure 2, It was confirmed that the longer the length of the child cluster fragment, the higher the productivity of bialaphos. In addition, as shown in FIG. 2, the productivity of bialaphos was improved when the full-length (full) fragment was introduced, compared to when the Sq3-6F3 fragment was introduced. ) was introduced, the productivity of bialaphos was significantly improved. This result suggested that the Sq1 and Sq2 regions especially contributed to the production of bialaphos. Furthermore, it was confirmed that the productivity of bialaphos was improved by adding alanine to the culture medium (data not shown). Here, the Sq1 and Sq2 regions are involved in the N-acetylglucosamine synthesis process in the bialaphos synthesis process. The gene encoding the enzyme involved in the reaction of adding two molecules of alanine to thyrophosphinothricin (phpA gene, phsB gene, and phsC gene) was included, suggesting that the addition of alanine is the rate-limiting step in the production of bialaphos. In addition, as shown in FIG. 2, the expression level of the Sq6F3 fragment was higher than that of the F3 fragment. The productivity of bialaphos was significantly improved when the Sq6 region was used. It was suggested that this contributes to the production of
[0088] [Example 2] Enhancement of gene expression in the region from Sq1 to Sq2 (Sq1-2 region) increased bialaphos productivity. We investigated whether further improvements were possible.
[0089] (1) Construction of plasmid for gene transfer First, the apramycin resistance gene of the autonomously replicating plasmid pGM1190 (addgene, #69994) A plasmid (pGK) was constructed in which the kanamycin resistance gene was replaced with the pGK gene. Streptomyces viridochromogenes ( S. viridochromogenes The pmi promoter region (SEQ ID NO: 1) of the base sequence shown in Table 4 was isolated by PCR using the genomic DNA of the JCM4977 strain as a template. 71) was amplified. The base sequences of the primers used (I-48 primer (SEQ ID NO: 72) and I-49 primer (SEQ ID NO: 73)) are shown in Table 5.
[0090] [Table 4] In the table, the base sequences are from left to right, from the 5' end to the 3' end.
[0091] [Table 5] In the table, the base sequences are from left to right, from the 5' end to the 3' end.
[0092] In addition, the transcription terminator region derived from pSET (SEQ ID NO: 1) with the base sequence shown in Table 6 was cloned by PCR. No. 76) was amplified. The base sequences of the primers used (I-54 primer (SEQ ID NO: 74) and I-55 primer (SEQ ID NO: 75)) are shown in Table 5.
[0093] [Table 6] In the table, the base sequences are from left to right, from the 5' end to the 3' end.
[0094] The EcoRI-SpeI fragment of Sq1 and the XbaI-HindIII fragment of Sq2 prepared in Example 1 were inserted into the EcoRI-HindIII gap of pUC19 (addgene, Cat. No. 50005) to construct Sq1-2 fragment.
[0095] The constructed Sq1-2 fragment was cleaved at the KpnI and SpeI sites upstream of the phpA initiation codon, EcoRI-KpnI fragment of the amplified pmi promoter region, amplified terminator region derived from pSET The plasmid was constructed by ligating this with the XbaI-HindIII fragment of pGK and inserting it into the EcoRI-HindIII gap of pGK.
[0096] (2) Transformation of E. coli for conjugation Except that 100 μg / mL kanamycin was used instead of 50 μg / mL apramycin. The constructed plasmid and empty vector (pGK) were transformed into E. coli for conjugation in the same manner as in Example 1. were transformed, respectively.
[0097] (3) Transformation of Streptomyces bacteria The use of 100 μg / mL kanamycin instead of 50 μg / mL apramycin, and and 20 μl of 100 mg / mL kanamycin instead of 50 mg / mL apramycin as the antibiotic solution. Streptomyces bacteria were transformed in the same manner as in Example 1, except that 10 μl of the vector was used.
[0098] (5) Jar culture 150 ml of YS medium (1% by weight soluble starch, 0.2% by weight yeast extract, 12.5 ppm kanamycin The strains containing the constructed plasmids and The empty vector-introduced strain (negative control) was inoculated and pre-cultured (28°C, 135 rpm) for 2 days. Then, 10 ml of the pre-culture solution was added to 150 ml of MYG medium (1% by weight of malt extract). The bacteria was inoculated into a 500 ml baffled flask containing 0.4% by weight glucose, 0.4% by weight yeast extract, 0.4% by weight glucose, and 12.5 ppm kanamycin, and precultured (28°C, 135 rpm) for 1 day. 15 ml of the obtained preculture solution was added to a 1 L jar culture solution (0.4% by weight glucose, 1.5% by weight malt extract, 1.2 ppm kanamycin). The bacteria were inoculated into 2 L of a 25% yeast extract, 0.0001 wt% CoCl2·6H2O, and 12.5 ppm kanamycin. The culture was carried out for 12 days in a fermenter apparatus at 28°C, pH 7.4, and aeration of 1 slpm (1 L / min). From the fourth day of culture onwards, the dissolved oxygen concentration was controlled at 0.5 ppm. 100 ml of supplemented medium (10% by weight glucose, 5% by weight yeast extract) was added.
[0099] (6) Measurement of Bialaphos concentration The culture medium on the 10th day of jar culture was taken and appropriately diluted, and then analyzed by LC-MS / MS to determine the concentration of the known compounds. The concentration of bialaphos was measured using a calibration curve prepared based on bialaphos.
[0100] (7) Results The bialaphos productivity of each transformant is shown in FIG. 3. As shown in FIG. The transfected strain was shown to have significantly improved bialaphos productivity compared to the empty vector-transfected strain.
Claims
1. A bacterium belonging to the genus Streptomyces, A bacterium that has been engineered to overexpress one or more genes contained in the bialaphos synthesis gene cluster, thereby enhancing the production of bialaphos.
2. The bacterium according to claim 1 , wherein the gene contained in the bialaphos synthesis gene cluster is any one of the following polynucleotides: a) a polynucleotide comprising one or more base sequences selected from the group consisting of SEQ ID NOs: 1 to 24; D b) A sequence complementary to one or more base sequences selected from the group consisting of SEQ ID NOs: 1 to 24. Polynucleotides that hybridize under gentle conditions c) a polypeptide encoding one or more amino acid sequences selected from the group consisting of SEQ ID NOs: 33 to 56; Ligands d) one or more amino acid sequences selected from the group consisting of SEQ ID NOs: 33 to 56 and 90% or more Polynucleotides encoding amino acid sequences with identity
3. The bacterium according to claim 1 , wherein the gene contained in the bialaphos synthesis gene cluster is any one of the following polynucleotides: a) A polynucleotide comprising the base sequence of SEQ ID NO: 1 to 4 b) Hybridization under stringent conditions with the complementary sequences of the base sequences of SEQ ID NOs: 1 to 4 Soybean Polynucleotides c) a polynucleotide encoding the amino acid sequence of SEQ ID NO: 33 to 36 d) an amino acid sequence having 90% or more identity with each of the amino acid sequences of SEQ ID NOs: 33 to 36; Polynucleotide encoding the acid sequence
4. The bacterium according to claim 1 , wherein the gene contained in the bialaphos synthesis gene cluster is any one of the following polynucleotides: a) A polynucleotide comprising the base sequence of SEQ ID NO: 14 to 24 b) Hybridization with the complementary sequences of the base sequences of SEQ ID NOs: 14 to 24 under stringent conditions Hybridizing polynucleotide c) a polynucleotide encoding the amino acid sequence of SEQ ID NO: 46 to 56 d) an amino acid sequence having 90% or more identity with each of the amino acid sequences of SEQ ID NOs: 46 to 56; Polynucleotide encoding the acid sequence
5. The bacterium described in claim 3, wherein the genes contained in the bialaphos synthetic gene cluster are polynucleotides comprising the base sequences of SEQ ID NOs: 26 and 27, or polynucleotides that hybridize under stringent conditions to the complementary sequences of SEQ ID NOs: 26 and 27, respectively.
6. The bacterium described in claim 4, wherein the genes contained in the bialaphos synthetic gene cluster are polynucleotides comprising the base sequences of SEQ ID NOs: 31 and 32, or polynucleotides that hybridize under stringent conditions to the complementary sequences of SEQ ID NOs: 31 and 32, respectively.
7. 2. The bacterium according to claim 1, which is a bacterium belonging to Streptomyces viridochromogenes or Streptomyces hygroscopicus.
8. A method for producing bialaphos, comprising the steps of: A production method comprising culturing the bacterium according to any one of claims 1 to 7 in a culture medium to produce and accumulate bialaphos in the culture medium and / or the bacterial cells.
